Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Drug Delivery Devices Market Research Report

  • Report Code: DR 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The drug delivery devices market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition, and improving patient compliance. The market was valued at $164 billion in 2013 and is expected to be $258 billion by 2018, at a CAGR of 9.50%. The oral delivery devices market is the fastest growing segment of $164 billion drug delivery devices market.

 

The report “Drug Delivery Devices Market Forecast, 2012-2018“, analyzes the market in terms of  technologies such as oral drug, transdermal, respiratory, injectable, implantable, trans-mucosal, nasal, ocular, and topical drug delivery devices. Oral drug delivery dominates the market as it is the most convenient route of administration and controlled release, a sub-segment, is a traditional, easy to adopt technology, with minimum manufacturing settings. In addition, the demand and use of orodispersible tablets (ODT) is on a rise for pediatric and geriatric patients. These factors have contributed to the large size of the oral drug delivery technology market.

 

Asia is the fastest growing market because of increase in aging population, development of healthcare expenditure, and high prevalence of chronic wounds. The pharmaceutical markets in India and China are growing rapidly due to low costs and favorable regulatory environments. The Indian pharmaceutical market was ranked 4th in terms of volume and 15th in terms of value in 2011. Asia accounts a share of 15.0% of the total drug delivery market in 2013 and was worth $30 billion. It is poised to grow at a double-digit CAGR of 12.6%, to reach $47 billion by 2018. The major factors propelling the Asian market are saturated western markets.

 

In North America (US and Canada) and Europe (Germany, France, Italy, Spain, and UK), the key drivers of this market is robust pharmaceutical industry, large number of pharmaceutical companies and drug delivery technology providers, and increasing number of collaborations and partnerships between them.

 

Europe accounts a share of 28.0% of the global market and was worth $45 billion in 2013. This region is estimated to grow at a CAGR of 8.20% to reach $65 billion by 2018. Key driver of the European market is large investment in R&D. In addition, the centralized approval process through the European Medicines Agency (EMA) enable pharmaceutical companies to sell their products in EU-27 nations which, encourages drug delivery technology and pharmaceutical companies introduce their products in the region. Due to certain amount of saturation in the market, North America and Europe are expected to grow at a slower speed.

 

The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in this report are 3M Company, Alkermes, Aptalis Pharma, Inc., Baxter International, Inc., Becton, Dickinson & Co., Catalent Pharma Solutions, The Dow Chemical Company, Endo Pharmaceuticals, Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, and Ypsomed Holding AG. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is also covered.

 

Customization Options

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get an insight into industry standards and deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • Applications of the products (segment and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Epidemiology Data

  • Country-specific prevalence and patient pool of chronic diseases
  • Disease progression (pattern analysis)

 

Surgeons’/Physicians’ Perception Analysis

  • Fast turn-around analysis of surgeon’s response to market events and trends
  • Pattern analysis of usage of products by physicians
  • Surgeons’ opinion about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Pricing Trend

  • Cost analysis of products in various countries.

 

Alternative Products: Impact analysis

 

MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (no. of hospitals, research labs, chronic disease population, reimbursement scenario, treatment rate and healthcare expenditure).

 



1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Injectables Drug Delivery devices
4.2 Respiratory drug delivery devices
4.3 Implantable Drug Delivery Devices
4.4 Intranasal Drug Delivery Systems
4.5 Transdermal Drug Delivery Systems
5 By Technologies
5.1 Smart Pill Technology (SPT)
5.2 Microfluidics
6 By Groups
6.1 Pharmaceutical Packaging

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Drug Delivery Devices Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Global Injectables Drug Delivery devices Market Global Injectables Drug Delivery devices Market
The Global Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $11.86 billion in 2013 and expected to be $20.04 billion by 2018, growing at a CAGR of 11.1%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Upcoming
Global Pulmonary drug delivery devices Market Global Pulmonary drug delivery devices Market
The Global Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $27.1 billion in 2013 and expected to be $48.2 billion by 2018, growing at a CAGR of 12.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
Global Implantable Drug Delivery Devices Market Global Implantable Drug Delivery Devices Market
The Global Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $9.05 billion in 2013 and expected to be $12.42 billion by 2018, growing at a CAGR of 6.5 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Upcoming
Intranasal Drug Delivery Systems Intranasal Drug Delivery Systems
Intranasal Drug Delivery Systems and Injectables Drug Delivery devices,
Upcoming
Global Transdermal Drug Delivery Systems Market Global Transdermal Drug Delivery Systems Market
The Global Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $13.5 billion in 2013 and expected to be $21.7 billion by 2018, growing at a CAGR of 11.1%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Drug Eluting Stents Drug Eluting Stents
Drug Eluting Stents and Infusion Pumps, Contraceptive...
Upcoming
Infusion Pumps Infusion Pumps
Infusion Pumps and Drug Eluting Stents, Contraceptive...
Upcoming
Contraceptive Implants Contraceptive Implants
Contraceptive Implants and Drug Eluting Stents, Infusion Pumps,...
Upcoming
Intravitreal Implants Intravitreal Implants
Intravitreal Implants and Drug Eluting Stents, Infusion Pumps,...
Upcoming
Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices
Conventional Injectable Drug delivery Devices and Self-injection Devices and Microneedles adds up to total
Upcoming
Self-injection Devices Self-injection Devices
Self-injection Devices and Conventional Injectable Drug delivery Devices and Microneedles adds up to total
Upcoming
Brachytherapy seed Brachytherapy seed
Brachytherapy seed and Drug Eluting Stents, Infusion Pumps,
Upcoming
Nasal Spray Nasal Spray
Nasal Spray and Nasal Inhalers adds up to total
Upcoming
Nasal Inhalers Nasal Inhalers
Nasal Inhalers and Nasal Spray adds up to total
Upcoming
Global Passive Transdermal Drug Delivery Market Global Passive Transdermal Drug Delivery Market
The Global Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $12.27 billion in 2013 and expected to be $20.59 billion by 2018, growing at a CAGR of 10.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Active Active
Active and Microfluidics, Smart Pill Technology (SPT) and Passive adds up to...
Upcoming
Prefilled Prefilled
Prefilled and Fillable adds up to total Injectables Drug...
Upcoming
Fillable Fillable
Fillable and Prefilled adds up to total Injectables Drug...
Upcoming
Disposable Disposable
Disposable and Reusable adds up to total Injectables Drug...
Upcoming
Reusable Reusable
Reusable and Disposable adds up to total Injectables Drug...
Upcoming
62 reports | Show
Connect With Us
US/CAN : +1-888-502-0539